A-APOTEKETS DOSISPAK P/S: Financial statements 2016
CVR: 36053941
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
A-APOTEKETS DOSISPAK P/S (CVR 36053941) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 495,747 and a net result of DKK -37,423. Equity in the 2016 report amounted to DKK 5,017,927. The solvency ratio was 78.1%.
- Gross Profit
- DKK 495,747
- Profit/Loss
- DKK -37,423
- Equity
- DKK 5,017,927
- Total Assets
- DKK 6,421,607
Official annual report
Find more companies like A-APOTEKETS DOSISPAK P/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
A-APOTEKETS DOSISPAK P/S has published its interim report for the period September 1, 2014 to December 31, 2015.
As of May 30, 2016, Vibeke Dengsø Toft-Petersen has joined the board of directors of A-APOTEKETS DOSISPAK P/S.
As of May 30, 2016, Doris Bechmann has left the board of directors of A-APOTEKETS DOSISPAK P/S.
As of May 30, 2016, Henrik Krog Jensen has left the board of directors of A-APOTEKETS DOSISPAK P/S.
As of May 30, 2016, Hans Bruun Ringsing has left the board of directors of A-APOTEKETS DOSISPAK P/S.
As of May 30, 2016, Bent Halling Sørensen has left the board of directors of A-APOTEKETS DOSISPAK P/S.
As of May 30, 2016, Cesare Cota has left the board of directors of A-APOTEKETS DOSISPAK P/S.
About A-APOTEKETS DOSISPAK P/S
A-APOTEKETS DOSISPAK P/S is a Danish company of the type Kommanditaktieselskab/Partnerselskab based in Hørsholm, founded in 2014. The company is registered under the industry Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events. The management consists of Lars Holm Jensen. The board consists of Jonas Arendal Grønskov (chair), Birgitte Pedersen, Cesare Cota and Nanna Stauner. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 660,491 and a net result of DKK 197,403 compared with DKK 263,755 the year before. Equity in the 2025 report amounted to DKK 5,425,978.